Europe Transdermal Patches Market Size, Share & Industry Trends Analysis Report By End User, By Distribution Channel, By Adhesive Type (Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others), By Patch Type, By Country and Growth Forecast, 2

Europe Transdermal Patches Market Size, Share & Industry Trends Analysis Report By End User, By Distribution Channel, By Adhesive Type (Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others), By Patch Type, By Country and Growth Forecast, 2023 - 2030


The Europe Transdermal Patches Market would witness market growth of 4.7% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 6,85,642.9 thousand units, showcasing a growth of 4.3% (2019-2022).

The applications of this span a wide range of therapeutic areas, reflecting the versatility of this drug delivery method. One of the notable applications is in pain management. Transdermal patches containing analgesic medications, such as opioids or nonsteroidal anti-inflammatory drugs (NSAIDs), are employed to provide sustained pain relief for conditions like osteoarthritis or chronic back pain. In the realm of cardiovascular health, these are utilized for the controlled release of medications to manage hypertension and angina.

The psychiatric field has embraced transdermal patches for the administration of medications to treat conditions like ADHD (attention deficit hyperactivity disorder) or to aid in smoking cessation. Nicotine replacement patches, for instance, have become a widely used tool in smoking cessation programs. Likewise, the dermatological applications of these are noteworthy as well. Patches delivering medications for conditions such as psoriasis or hormone imbalances are designed to act directly on the skin, demonstrating the flexibility of this delivery method in addressing diverse medical needs.

Cardiovascular diseases, including hypertension and angina, are major contributors to the burden of chronic diseases in Europe. These for cardiovascular medications provide a convenient and controlled delivery method, supporting patient adherence to treatment regimens. Chronic pain conditions, such as osteoarthritis and back pain, are becoming more prevalent in the European population. These with analgesic medications provide a non-invasive and targeted approach to pain management, offering continuous relief over an extended period. Thus, growing numbers of chronic diseases in Europe will boost the demand in the region.

The Germany market dominated the Europe Transdermal Patches Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $533.3 million by 2030. The UK market is exhibiting a CAGR of 3.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 5.5% during (2023 - 2030).

Based on End User, the market is segmented into Homecare Settings and Hospitals & Clinics. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on Adhesive Type, the market is segmented into Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others. Based on Patch Type, the market is segmented into Drug-In-Adhesive, Matrix Patches, Reservoir Membrane Patches, Microneedle Patches, Iontophoresis Patches and Vapour Patches. Based on Application, the market is segmented into Pain Management, Smoking Cessation, Hormone Replacement Therapy, Cardiovascular Disorder, Central Nervous System Disorder and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Viatris, Inc. (Mylan N.V.), Boehringer Ingelheim International GmbH, Endo International PLC, Bayer AG, Nitto Denko Corporation, Cipla Limited, Amneal Pharmaceuticals, Inc., Novartis AG, and AbbVie, Inc.

Scope of the Study

Market Segments covered in the Report:

By End User (Volume, Thousand Units, USD Billion, 2019-2030)
  • Homecare Settings
  • Hospitals & Clinics
By Distribution Channel (Volume, Thousand Units, USD Billion, 2019-2030)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Adhesive Type (Volume, Thousand Units, USD Billion, 2019-2030)
  • Acrylic Adhesives
  • Silicone Adhesives
  • Hydrogel Adhesives
  • Others
By Patch Type (Volume, Thousand Units, USD Billion, 2019-2030)
  • Drug-In-Adhesive
  • Matrix Patches
  • Reservoir Membrane Patches
  • Microneedle Patches
  • Iontophoresis Patches
  • Vapour Patches
By Application (Volume, Thousand Units, USD Billion, 2019-2030)
  • Pain Management
  • Smoking Cessation
  • Hormone Replacement Therapy
  • Cardiovascular Disorder
  • Central Nervous System Disorder
  • Others
By Country (Volume, Thousand Units, USD Billion, 2019-2030)
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Johnson & Johnson
  • Viatris, Inc. (Mylan N.V.)
  • Boehringer Ingelheim International GmbH
  • Endo International PLC
  • Bayer AG
  • Nitto Denko Corporation
  • Cipla Limited
  • Amneal Pharmaceuticals, Inc.
  • Novartis AG
  • AbbVie, Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Transdermal Patches Market, by End User
1.4.2 Europe Transdermal Patches Market, by Distribution Channel
1.4.3 Europe Transdermal Patches Market, by Adhesive Type
1.4.4 Europe Transdermal Patches Market, by Patch Type
1.4.5 Europe Transdermal Patches Market, by Application
1.4.6 Europe Transdermal Patches Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2022
4.2 Porter’s Five Forces Analysis
Chapter 5. Europe Transdermal Patches Market by End User
5.1 Europe Homecare Settings Market by Country
5.2 Europe Hospitals & Clinics Market by Country
Chapter 6. Europe Transdermal Patches Market by Distribution Channel
6.1 Europe Hospital Pharmacies Market by Country
6.2 Europe Retail Pharmacies Market by Country
6.3 Europe Online Pharmacies Market by Country
Chapter 7. Europe Transdermal Patches Market by Adhesive Type
7.1 Europe Acrylic Adhesives Market by Country
7.2 Europe Silicone Adhesives Market by Country
7.3 Europe Hydrogel Adhesives Market by Country
7.4 Europe Others Market by Country
Chapter 8. Europe Transdermal Patches Market by Patch Type
8.1 Europe Drug-In-Adhesive Market by Country
8.2 Europe Matrix Patches Market by Country
8.3 Europe Reservoir Membrane Patches Market by Country
8.4 Europe Microneedle Patches Market by Country
8.5 Europe Iontophoresis Patches Market by Country
8.6 Europe Vapour Patches Market by Country
Chapter 9. Europe Transdermal Patches Market by Application
9.1 Europe Pain Management Market by Country
9.2 Europe Smoking Cessation Market by Country
9.3 Europe Hormone Replacement Therapy Market by Country
9.4 Europe Cardiovascular Disorder Market by Country
9.5 Europe Central Nervous System Disorder Market by Country
9.6 Europe Others Market by Country
Chapter 10. Europe Transdermal Patches Market by Country
10.1 Germany Transdermal Patches Market
10.1.1 Germany Transdermal Patches Market by End User
10.1.2 Germany Transdermal Patches Market by Distribution Channel
10.1.3 Germany Transdermal Patches Market by Adhesive Type
10.1.4 Germany Transdermal Patches Market by Patch Type
10.1.5 Germany Transdermal Patches Market by Application
10.2 UK Transdermal Patches Market
10.2.1 UK Transdermal Patches Market by End User
10.2.2 UK Transdermal Patches Market by Distribution Channel
10.2.3 UK Transdermal Patches Market by Adhesive Type
10.2.4 UK Transdermal Patches Market by Patch Type
10.2.5 UK Transdermal Patches Market by Application
10.3 France Transdermal Patches Market
10.3.1 France Transdermal Patches Market by End User
10.3.2 France Transdermal Patches Market by Distribution Channel
10.3.3 France Transdermal Patches Market by Adhesive Type
10.3.4 France Transdermal Patches Market by Patch Type
10.3.5 France Transdermal Patches Market by Application
10.4 Russia Transdermal Patches Market
10.4.1 Russia Transdermal Patches Market by End User
10.4.2 Russia Transdermal Patches Market by Distribution Channel
10.4.3 Russia Transdermal Patches Market by Adhesive Type
10.4.4 Russia Transdermal Patches Market by Patch Type
10.4.5 Russia Transdermal Patches Market by Application
10.5 Spain Transdermal Patches Market
10.5.1 Spain Transdermal Patches Market by End User
10.5.2 Spain Transdermal Patches Market by Distribution Channel
10.5.3 Spain Transdermal Patches Market by Adhesive Type
10.5.4 Spain Transdermal Patches Market by Patch Type
10.5.5 Spain Transdermal Patches Market by Application
10.6 Italy Transdermal Patches Market
10.6.1 Italy Transdermal Patches Market by End User
10.6.2 Italy Transdermal Patches Market by Distribution Channel
10.6.3 Italy Transdermal Patches Market by Adhesive Type
10.6.4 Italy Transdermal Patches Market by Patch Type
10.6.5 Italy Transdermal Patches Market by Application
10.7 Rest of Europe Transdermal Patches Market
10.7.1 Rest of Europe Transdermal Patches Market by End User
10.7.2 Rest of Europe Transdermal Patches Market by Distribution Channel
10.7.3 Rest of Europe Transdermal Patches Market by Adhesive Type
10.7.4 Rest of Europe Transdermal Patches Market by Patch Type
10.7.5 Rest of Europe Transdermal Patches Market by Application
Chapter 11. Company Profiles
11.1 Johnson & Johnson
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 SWOT Analysis
11.2 Viatris, Inc. (Mylan N.V.)
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.6 SWOT Analysis
11.3 Boehringer Ingelheim International GmbH
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Regional & Segmental Analysis
11.3.4 Research & Development Expenses
11.3.5 SWOT Analysis
11.4 Endo International PLC
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental Analysis
11.4.4 Research & Development Expense
11.4.5 SWOT Analysis
11.5 Bayer AG
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 SWOT Analysis
11.6 Nitto Denko Corporation
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental Analysis
11.6.4 Research & Development Expense
11.6.5 SWOT Analysis
11.7 Cipla Limited
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Acquisition and Mergers:
11.7.6 SWOT Analysis
11.8 Amneal Pharmaceuticals, Inc.
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Product Launches and Product Expansions:
11.8.6 SWOT Analysis
11.9 Novartis AG
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.9.5 SWOT Analysis
11.10. AbbVie, Inc.
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Regional Analysis
11.10.4 Research & Development Expense
11.10.5 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings